BackLennox International Overview
Lennox International Inc

Lennox International Target Price

Analysts' average 12-month price target for Lennox International is $450.

Get informed when a big investor buys or sells

+ Follow

Share Price

$356.3

Average Target Price

$451.8026.8% upside

5 analysts in the last 4 months

High: $547 | Low: $375

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-24Wells FargoStephen Tusa$42419% upsideOpen
2026-09-14Deutsche Bank$44424.6% upsideOpen
2026-09-03Morgan StanleyChristopher Snyder$3755.2% upsideOpen
2026-07-31Goldman SachsJoe Ritchie$54753.5% upsideOpen
2026-07-30RBC CapitalDeane Dray$46931.6% upsideOpen
2026-04-30OppenheimerNoah Kaye$65082.4% upsideOpen
2026-04-30Robert W. Baird$55054.4% upsideOpen
2026-04-30Vertical Research$60068.4% upsideOpen
2026-04-30Barclays$59767.6% upsideOpen
2026-04-14BNP Paribas$53550.2% upsideOpen
2026-02-01Morgan Stanley$45026.3% upsideOpen
2026-01-31Goldman Sachs$59266.2% upsideOpen
2026-01-29RBC CapitalDeane Dray$53449.9% upsideOpen
2026-01-29Oppenheimer$63076.8% upsideOpen
2026-01-29Robert W. Baird$57260.5% upsideOpen
2026-01-29Mizuho Securities$52547.3% upsideOpen
2026-01-15RBC CapitalDeane Dray$56358% upsideOpen
2026-01-07BarclaysJulian Mitchell$66787.2% upsideOpen
2026-01-05UBS$53048.8% upsideOpen
2025-12-11BarclaysJulian Mitchell$68090.9% upsideOpen
2025-12-04Wells FargoJoseph O'Dea$52547.3% upsideOpen
2025-10-27UBSDamian Karas$56057.2% upsideOpen
2025-10-27Northcoast ResearchAaron Reed$52547.3% upsideOpen
2025-10-23RBC Capital$55555.8% upsideOpen
2025-10-23Wells FargoJoseph O'Dea$54553% upsideOpen
2025-10-23Morgan StanleyChristopher Snyder$47533.3% upsideOpen
2025-10-23Barclays$70096.5% upsideOpen
2025-10-17Mizuho Securities$56558.6% upsideOpen
2025-10-06Wells FargoJoseph O'Dea$57561.4% upsideOpen
2025-07-28UBSDamian Karas$67689.7% upsideOpen
2025-04-24OppenheimerNoah Kaye$60068.4% upsideOpen
2025-02-03Wells FargoJoseph O'Dea$58062.8% upsideOpen
2024-10-24Mizuho SecuritiesBrett Linzey$67589.4% upsideOpen
2024-10-24RBC CapitalDeane Dray$61973.7% upsideOpen
2024-10-24BarclaysJulian Mitchell$62475.1% upsideOpen
2024-10-15KeyBancJeffrey Hammond$60068.4% upsideOpen
2024-10-14Robert W. BairdTimothy Wojs$64881.9% upsideOpen
2024-07-15Robert W. BairdTimothy Wojs$61071.2% upsideOpen
2024-07-09Wells FargoJoseph O'Dea$57060% upsideOpen
2024-04-25Wells FargoJoseph O'Dea$52045.9% upsideOpen
2024-04-25RBC CapitalDeane Dray$51043.1% upsideOpen
2024-04-10KeyBancJeffrey Hammond$51544.5% upsideOpen
2024-04-04RBC CapitalDeane Dray$48135% upsideOpen
2023-10-16Mizuho SecuritiesBrett Linzey$46029.1% upsideOpen
2023-08-17RBC CapitalDeane Dray$3919.7% upsideOpen
2023-02-01Wells Fargo$30015.8% downsideOpen
2023-01-06Morgan Stanley$25827.6% downsideOpen
2023-01-05Wells Fargo$29417.5% downsideOpen
2022-12-15UBSDamian Karas$26525.6% downsideOpen
2022-12-15Morgan Stanley$27921.7% downsideOpen

Lennox International (LII) FAQ

Lennox International (LII) currently reports a target price of $450. Use the charts on this page to explore Lennox International's target price history and peer comparisons.

Analysts' average 12-month price target for Lennox International is $450, about 26.8% upside from the current share price of $356.3. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $450, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lennox International, and consider following LII for alerts when major investors trade the stock.

Lennox International is classified in the Industrials sector. On target price, it currently shows $450. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing LII with unrelated industries.